Metagenomic Sequencing Market by Workflow (Sample Preparation, Data Analysis), Product & Services (Reagents, Consumables, Instruments), Technology (Shotgun, 16s Rrna, Whole-Genome), Application (Diagnostic, Soil Microbiome) - Global Forecast to 2024

メタゲノムシーケンシングの世界市場予測(~2024年)

◆タイトル:Metagenomic Sequencing Market by Workflow (Sample Preparation, Data Analysis), Product & Services (Reagents, Consumables, Instruments), Technology (Shotgun, 16s Rrna, Whole-Genome), Application (Diagnostic, Soil Microbiome) - Global Forecast to 2024
◆商品コード:BT 7350
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年9月13日
◆ページ数:150
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、メタゲノムシーケンシングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、ワークフロー別(サンプル準備、データ分析)分析、製品&サービス別(試薬、消耗品、機器)分析、技術別(ショットガン、16代Rrna、全ゲノム)分析、用途別(診断、土壌微生物叢)分析、メタゲノムシーケンシングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、メタゲノムシーケンシングの世界市場規模が2019年10億ドルから2024年23億ドルまで年平均17.0%成長すると予測しています。

“The metagenomic sequencing market is projected to grow at a CAGR of 17.0%.”The metagenomic sequencing market is projected to reach USD 2.3 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 17.0%. The growth of this market is driven by factors such as the significant applications of metagenomics in various fields, the various initiatives and funding from government & private bodies for large-scale sequencing projects, and the declining cost of sequencing.

“The reagents & consumables segment is expected to witness the highest growth in the metagenomic sequencing market during the forecast period.”
On the basis of product & service, the metagenomic sequencing market is segmented into reagents & consumables, instruments, services, and analysis & data interpretation solutions. Of all these segments, reagents & consumables are expected to grow at the highest CAGR during the forecast period. Factors such as the development and commercialization of high-quality reagents and kits and the continuous requirement of sequencing reagents by end users are expected to drive the growth of the reagents & consumables market in the coming years.

“The sample processing & library preparation segment is expected to witness the highest growth in the metagenomic sequencing market during the forecast period.”
The market, based on workflow, has been segmented into sample processing & library preparation, sequencing, and data processing & analysis. The sample processing & library preparation segment projected to register the highest growth rate during the forecast period. This growth can be attributed to the growing number of metagenome sequencing research projects being conducted, the availability of technically advanced and robust sample processing and library preparation assay kits, and the demand for efficient library preparation products.

“The shotgun metagenomic sequencing technology segment is expected to witness the highest growth in the metagenomic sequencing market during the forecast period.”
On the basis of technology, the metagenomic sequencing market is segmented into shotgun metagenomic sequencing, 16S rRNA sequencing, metatranscriptomics, and whole-genome sequencing & de-novo assembly. The shotgun metagenomic sequencing technology is expected to witness the highest growth rate in the metagenomic sequencing market during the forecast period. This can be attributed to the advantages offered by shotgun sequencing over other techniques, growing adoption of shotgun metagenomic sequencing among researchers and healthcare professionals, and the increasing number of metagenomic sequencing-based research activities.

“The drug discovery segment is expected to witness the highest growth in the metagenomic sequencing market during the forecast period.”
Based on applications, the metagenomic sequencing market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological and environmental applications, veterinary applications, and other applications. The drug discovery segment is poised to grow at the highest rate during the forecast period. Growth in this market segment is mainly due to the increasing research activities for novel drug discovery, growing collaborations between market players, academic institutions, and pharmaceutical companies for drug development, and growing use of metagenomic NGS in clinical trials.

“The Asia Pacific is expected to grow at the highest CAGR during the forecast period.”
The metagenomic sequencing market is segmented into four major regions, namely, North America, Europe, the Asia Pacific (APAC), and the Rest of the World (Latin America, the Middle East, and Africa). The Asia Pacific regional segment is expected to grow at the highest CAGR during the forecast period. Growth in this market segment is mainly due to a significant focus on R&D activities as a means of broadening the scope of metagenomics applications, increasing adoption of metagenomics for diagnostics (due to the decreasing cost of metagenomics products and services), and technological developments in metagenomics genomic data analysis as well as interpretation.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (45%)
• By Designation: C-level (26%), Director-level (30%), and Others (44%)
• By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

The major players operating in the global metagenomic sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc (US), QIAGEN N.V. (Netherlands), PerkinElmer (US), Oxford Nanopore Technologies Ltd (UK), BGI Group (China), Macrogen Inc. (South Korea), GENEWIZ (US), Eurofins Scientific (Luxembourg), Novogene Corporation (China), Zymo Research Corporation (US), NuGEN Technologies, Inc (US), IntegraGen SA (France), Microsynth AG (Switzerland), and DNAStar, Inc (US).

Research Coverage
This report studies the metagenomic sequencing market by product & service, workflow, technology, application, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends and forecasts the size of market segments with respect to key regions—North America, Europe, the Asia Pacific, and the Rest of the World.

Reasons to Buy the Report:
From an insights perspective, this research report focuses on various levels of analysis—market ranking the analysis of the top players and their company profiles, which together comprise and discuss basic views on the competitive landscape; emerging segments of the metagenomic sequencing market and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

【レポートの目次】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Market Stakeholders
2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
2.2.2 Application-Based Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 27)
4 Premium Insights (Page No. – 31)
4.1 Metagenomic Sequencing: Market Overview
4.2 Metagenomic Sequencing Market Share, By Product & Service (2019 vs. 2024)
4.3 Market Share, By Workflow (2019 vs. 2024)
4.4 Market Share, By Technology (2019 vs. 2024)
4.5 Market, By Application, (2019 vs. 2024)
4.6 Market, By Region (2019–2024)
5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Significant Applications of Metagenomics in Various Fields
5.2.1.2 Initiatives and Funding From Government & Private Bodies for Large-Scale Sequencing Projects
5.2.1.3 Declining Cost of Sequencing
5.2.2 Restraints
5.2.2.1 End-User Budget Constraints in Developing Countries
5.2.3 Opportunities
5.2.3.1 Availability of Cloud Computing for Data Management
5.2.4 Challenges
5.2.4.1 Storage of Sequencing Data
5.2.4.2 Dearth of Skilled Professionals
6 Metagenomic Sequencing Market, By Product & Service (Page No. – 39)
6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Rising Adoption of Metagenomic Sequencing is Driving the Use of Reagents and Consumables
6.3 Instruments
6.3.1 Launch of Advanced Ngs Platforms Will Support the Growth of This Segment
6.4 Services
6.4.1 Time and Cost-Effectiveness of Outsourcing Ngs Projects has Driven Demand for Services
6.5 Analysis and Data Interpretation Solutions
6.5.1 Limited Technical Knowledge of Advanced Analysis Solutions Among End Users to Hamper Market Growth
7 Metagenomic Sequencing Market, By Workflow (Page No. – 45)
7.1 Introduction
7.2 Sample Processing & Library Preparation
7.2.1 Sample Processing & Library Preparation Holds the Largest Share of the Market, By Workflow
7.3 Sequencing
7.3.1 Sanger Sequencing has Been Supplanted By Ngs Due to Its Advantages and Rapidity
7.4 Data Processing & Analysis
7.4.1 Need for Skilled Personnel to Operate Data Processing and Analytics Tools has Slowed Market Growth
8 Metagenomic Sequencing Market, By Technology (Page No. – 49)
8.1 Introduction
8.2 16s Rrna Sequencing
8.2.1 16s Rrna Sequencing is A Cost-Effective Technique for the Identification of Bacterial Strains
8.3 Shotgun Metagenomic Sequencing
8.3.1 Shotgun Metagenomic Sequencing Segment to Witness the Highest Growth Rate During the Forecast Period
8.4 Whole-Genome Sequencing and De Novo Assembly
8.4.1 Wgs Can Sequence the Complete Metagenome of Environmental Samples & Helps Generate Accurate Reference Genomes for Microbial Identification
8.5 Metatranscriptomics
8.5.1 Metatranscriptomics Helps in the Understanding of the Active Functional Profile of A Microbial Community
9 Metagenomic Sequencing Market, By Application (Page No. – 56)
9.1 Introduction
9.2 Drug Discovery
9.2.1 Drug Discovery Accounts for the Largest Share of the Market
9.3 Ecological & Environmental Applications
9.3.1 Metagenomic Sequencing Can Help Identify Invasive and Endangered Species
9.4 Clinical Diagnostics
9.4.1 Advantages of Metagenomic Ngs Have Enabled Wide Applications in Diagnostics
9.5 Soil Microbiome Applications
9.5.1 North America Shows High Demand for Metagenomic Sequencing in Soil Microbiome Applications
9.6 Industrial Applications
9.6.1 Energy
9.6.1.1 Declining Fossil Fuel Reserves and Growing Energy Needs Will Drive Demand Growth in This Application Segment
9.6.2 Bioremediation
9.6.2.1 Need to Monitor Pollutant Impact and Contamination Will Provide Opportunities for Metagenomic Sequencing in Bioremediation
9.6.3 Other Industrial Applications
9.7 Veterinary Applications
9.7.1 Demand for Rapid and Accurate Pathogen Diagnosis is Supporting Demand for Sequencing
9.8 Other Applications
10 Metagenomic Sequencing Market, By Region (Page No. – 67)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Well-Established Infrastructure and Funding Sources Required for Overall Ngs Based Small- and Medium-Sized Research Studies and Projects Make the US the Largest Market in North America
10.2.2 Canada
10.2.2.1 Growing Focus of Ngs Players on Expanding their Presence in Canada and Increasing Government Initiatives to Support Genomics Research and Workshops to Support Growth in This Market
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany has Witnessed A Significant Increase in Investments in Next-Generation Technologies, Making It the Largest Market in Europe
10.3.2 UK
10.3.2.1 The UK is One of the Leaders in Biotechnology in the European Region Owing to the Presence of A Large Number of Ngs Players in the Country
10.3.3 France
10.3.3.1 Government Initiatives to Support Genomics Research are Primarily Driving the Growth of the Metagenomic Sequencing Market in France
10.3.4 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Several Ngs Players are Focusing on Strengthening their Presence and Offerings in China
10.4.2 Japan
10.4.2.1 Rising Use of Metagenomic Sequencing for Various Application to Drive Market Growth in Japan
10.4.3 India
10.4.3.1 Decreasing Cost of Sequencing to Drive Market Growth in India
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Latin America
10.5.2 Middle East
10.5.3 Africa
11 Competitive Landscape (Page No. – 95)
11.1 Introduction
11.2 Market Ranking Analysis
11.3 Competitive Scenario
11.3.1 Acquisitions
11.3.2 Agreements
11.4 Competitive Leadership Mapping
11.4.1 Competitive Leadership Mapping: Major Market Players (2018)
11.4.2 Visionary Leaders
11.4.3 Innovators
11.4.4 Dynamic Players
11.4.5 Emerging Companies
12 Company Profiles (Page No. – 100)
12.1 BGI Group
12.2 DNAstar, Inc.
12.3 Eurofins Scientific
12.4 GENEWIZ
12.5 Illumina, Inc.
12.6 Integragen SA
12.7 Macrogen, Inc.
12.8 Microsynth AG
12.9 Novogene Co., Ltd.
12.10 NuGEN Technologies, Inc. (A Wholly Owned Subsidiary of Tecan Trading AG)
12.11 Oxford Nanopore Technologies, Ltd.
12.12 Perkinelmer, Inc.
12.13 QIAGEN N.V.
12.14 Thermo Fisher Scientific, Inc.
12.15 Zymo Research Corporation
13 Appendix (Page No. – 142)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details

List of Tables (60 Tables)
Table 1 Metagenomic Sequencing Market, By Product & Service, 2017–2024 (USD Million)
Table 2 Metagenomic Sequencing Reagents and Consumables Market, By Region, 2017–2024 (USD Million)
Table 3 Metagenomic Sequencing Instruments Market, By Region, 2017–2024 (USD Million)
Table 4 Metagenomic Sequencing Services Market, By Region, 2017–2024 (USD Million)
Table 5 Metagenomic Sequencing Analysis and Data Interpretation Solutions Market, By Region, 2017–2024 (USD Million)
Table 6 Metagenomic Sequencing Market, By Workflow, 2017–2024 (USD Million)
Table 7 Sample Processing & Library Preparation Market, By Region, 2017–2024 (USD Million)
Table 8 Sequencing Market, By Region, 2017–2024 (USD Million)
Table 9 Data Processing & Analysis Market, By Region, 2017–2024 (USD Million)
Table 10 Market, By Technology, 2017–2024 (USD Million)
Table 11 16s Rrna Sequencing Market, By Region, 2017–2024 (USD Million)
Table 12 Shotgun Market, By Region, 2017–2024 (USD Million)
Table 13 Whole-Genome Sequencing and De Novo Assembly Market, By Region, 2017–2024 (USD Million)
Table 14 Metatranscriptomics Market, By Region, 2017–2024 (USD Million)
Table 15 Metagenomic Sequencing Market, By Application, 2017–2024 (USD Million)
Table 16 Market for Drug Discovery, By Region, 2017–2024 (USD Million)
Table 17 Market for Ecological & Environmental Applications, By Region, 2017–2024 (USD Million)
Table 18 Market for Clinic Diagnostics, By Region, 2017–2024 (USD Million)
Table 19 Metagenomic Sequencing Market for Soil Microbiome Applications, By Region, 2017–2024 (USD Million)
Table 20 Market for Industrial Applications, By Region, 2017–2024 (USD Million)
Table 21 Market for Industrial Applications, By Type, 2017–2024 (USD Million)
Table 22 Market for Energy, By Region, 2017–2024 (USD Million)
Table 23 Market for Bioremediation, By Region, 2017–2024 (USD Million)
Table 24 Metagenomic Sequencing Market for Other Industrial Applications, By Region, 2017–2024 (USD Million)
Table 25 Market for Veterinary Applications, By Region, 2017–2024 (USD Million)
Table 26 Market for Other Applications, By Region, 2017–2024 (USD Million)
Table 27 Metagenomic Sequencing Market, By Region, 2017–2024 (USD Million)
Table 28 North America: Market, By Country, 2017–2024 (USD Million)
Table 29 North America: Market, By Product & Service, 2017–2024 (USD Million)
Table 30 North America: Market, By Workflow, 2017–2024 (USD Million)
Table 31 North America: Market, By Technology, 2017–2024 (USD Million)
Table 32 North America: ncing Market, By Application, 2017–2024 (USD Million)
Table 33 US: Metagenomic Sequencing Market, By Product & Service, 2017–2024 (USD Million)
Table 34 Canada: Market, By Product & Service, 2017–2024 (USD Million)
Table 35 Europe: Market, By Country, 2017–2024 (USD Million)
Table 36 Europe: Market, By Product & Service, 2017–2024 (USD Million)
Table 37 Europe: Market, By Workflow, 2017–2024 (USD Million)
Table 38 Europe: Market, By Technology, 2017–2024 (USD Million)
Table 39 Europe: Market, By Application, 2017–2024 (USD Million)
Table 40 Germany: Metagenomic Sequencing Market, By Product & Service, 2017–2024 (USD Million)
Table 41 UK: Market, By Product & Service, 2017–2024 (USD Million)
Table 42 France: Market, By Product & Service, 2017–2024 (USD Million)
Table 43 RoE: Market, By Product & Service, 2017–2024 (USD Million)
Table 44 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 45 Asia Pacific: Market, By Product & Service, 2017–2024 (USD Million)
Table 46 Asia Pacific: Market, By Workflow, 2017–2024 (USD Million)
Table 47 Asia Pacific: Metagenomic Sequencing Market, By Technology, 2017–2024 (USD Million)
Table 48 Asia Pacific: Market, By Application, 2017–2024 (USD Million)
Table 49 China: Market, By Product & Service, 2017–2024 (USD Million)
Table 50 Japan: Market, By Product & Service, 2017–2024 (USD Million)
Table 51 India: Market, By Product & Service, 2017–2024 (USD Million)
Table 52 RoAPAC: Market, By Product & Service, 2017–2024 (USD Million)
Table 53 RoW: Market, By Region, 2017–2024 (USD Million)
Table 54 RoW: Market, By Product & Service, 2017–2024 (USD Million)
Table 55 RoW: Market, By Workflow, 2017–2024 (USD Million)
Table 56 RoW: Market, By Technology, 2017–2024 (USD Million)
Table 57 RoW: Market, By Application, 2017–2024 (USD Million)
Table 58 Latam: Market, By Product & Service, 2017–2024 (USD Million)
Table 59 Middle East: Metagenomic Sequencing Market, By Product & Service, 2017–2024 (USD Million)
Table 60 Africa: Market, By Product & Service, 2017–2024 (USD Million)

List of Figures (30 Figures)
Figure 1 Metagenomic Sequencing Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Product-Based Market Estimation: Market
Figure 5 Application-Based Market Size Estimation: Market
Figure 6 Metagenomic Sequencing Market: Data Triangulation
Figure 7 Market, By Product & Service, 2019 vs. 2024 (USD Million)
Figure 8 Market, By Workflow, 2019 vs. 2024 (USD Million)
Figure 9 Market, By Technology, 2019 vs. 2024 (USD Million)
Figure 10 Market, By Application, 2019 vs. 2024 (USD Million)
Figure 11 Market, By Region, 2019–2024
Figure 12 Significant Applications of Metagenomics in Various Fields to Drive Growth in the Market
Figure 13 Reagents & Consumables Held the Largest Share of the Market in 2018
Figure 14 Sample Processing & Library Preparation Accounted for the Largest Share of the Market in 2018
Figure 15 Shotgun Metagenomic Sequencing Technology is Expected to Witness the Highest Growth Rate During Forecast Period
Figure 16 Drug Discovery Segment Accounted for the Largest Share of the Metagenomic Sequencing Market During the Forecast Period
Figure 17 APAC to Grow at the Highest CAGR During the Forecast Period
Figure 18 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 North America: Market Snapshot
Figure 20 Asia Pacific: Market Snapshot
Figure 21 Metagenomics Sequencing Market Ranking, By Key Player, 2018
Figure 22 Metagenomic Sequencing Market (Global) Competitive Leadership Mapping, 2018
Figure 23 Eurofins Scientific: Company Snapshot, 2018
Figure 24 Brooks Automation, Inc.: Company Snapshot, 2018
Figure 25 Illumina, Inc.: Company Snapshot, 2018
Figure 26 Integragen SA: Company Snapshot, 2018
Figure 27 Tecan Trading AG: Scientific: Company Snapshot, 2018
Figure 28 Perkinelmer, Inc.: Company Snapshot, 2018
Figure 29 QIAGEN N.V.: Company Snapshot, 2018
Figure 30 Thermo Fisher Scientific Inc.: Company Snapshot, 2018

★調査レポート[メタゲノムシーケンシングの世界市場予測(~2024年)] ( Metagenomic Sequencing Market by Workflow (Sample Preparation, Data Analysis), Product & Services (Reagents, Consumables, Instruments), Technology (Shotgun, 16s Rrna, Whole-Genome), Application (Diagnostic, Soil Microbiome) - Global Forecast to 2024 / BT 7350) 販売に関する免責事項
[メタゲノムシーケンシングの世界市場予測(~2024年)] ( Metagenomic Sequencing Market by Workflow (Sample Preparation, Data Analysis), Product & Services (Reagents, Consumables, Instruments), Technology (Shotgun, 16s Rrna, Whole-Genome), Application (Diagnostic, Soil Microbiome) - Global Forecast to 2024 / BT 7350) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆